| Sun Pharma Advanced Research Company Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532872 |
NSE Symbol : SPARC |
P/E(TTM) : 3.90 |
|
ISIN Demat : INE232I01014 |
Div & Yield% : 0.00 |
EPS(TTM) : 49.17 |
|
Book Value(₹) : 41.09 |
Market Cap(₹Cr) : 6,222.70 |
Face Value(₹) : 1.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 39.92 | 13.20 | 8.45 | 7.86 | 9.64 | 27.19 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 39.92 | 13.20 | 8.45 | 7.86 | 9.64 | 27.19 |
| Other Operating Income | 0.00 | 1,840.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 23.66 | 1.80 | 0.00 | 0.01 | 9.02 | 0.00 |
| Total Income | 63.58 | 1,855.02 | 8.45 | 7.87 | 18.66 | 27.19 |
| Total Expenditure | 74.23 | 80.28 | 77.68 | 73.75 | 61.97 | 81.11 |
| PBIDT | -10.65 | 1,774.74 | -69.23 | -65.88 | -43.31 | -53.92 |
| Interest | 8.13 | 11.64 | 8.78 | 7.52 | 6.18 | 4.51 |
| PBDT | -18.78 | 1,763.10 | -78.01 | -73.40 | -49.49 | -58.43 |
| Depreciation | 2.20 | 2.40 | 2.56 | 2.57 | 2.54 | 2.55 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | -20.98 | 1,760.70 | -80.57 | -75.97 | -52.03 | -60.98 |
| Extra-ordinary Items | 0.00 | 0.00 | -12.36 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -20.98 | 1,760.70 | -68.21 | -75.97 | -52.03 | -60.98 |
| EPS (Unit Curr.) | -0.65 | 54.26 | -2.48 | -2.34 | -1.60 | -1.88 |
| EPS (Adj) (Unit Curr.) | -0.65 | 54.26 | -2.48 | -2.34 | -1.60 | -1.88 |
| Calculated EPS (Unit Curr.) | -0.65 | 54.26 | -2.48 | -2.34 | -1.60 | -1.88 |
| Calculated EPS (Adj) (Unit Curr.) | -0.65 | 54.26 | -2.48 | -2.34 | -1.60 | -1.88 |
| Calculated EPS (Ann.) (Unit Curr.) | -2.59 | 217.04 | -9.93 | -9.36 | -6.41 | -7.52 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -2.59 | 217.04 | -9.93 | -9.36 | -6.41 | -7.52 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 32.45 | 32.45 | 32.45 | 32.45 | 32.45 | 32.45 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -26.68 | 13,445.00 | -819.29 | -838.17 | -449.27 | -198.31 |
| PBDTM(%) | -47.04 | 13,356.82 | -923.20 | -933.84 | -513.38 | -214.90 |
| PATM(%) | -52.56 | 13,338.64 | -953.49 | -966.54 | -539.73 | -224.27 |
